Maze Therapeutics, Inc. (MAZE)
32.58
+0.13
(+0.40%)
USD |
NASDAQ |
Oct 21, 16:00
32.53
-0.05
(-0.15%)
After-Hours: 20:00
Maze Therapeutics Price to Book Value : 3.991 for Oct. 21, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 21, 2026 | 3.991 |
| October 20, 2026 | 3.975 |
| October 19, 2026 | 3.638 |
| October 16, 2026 | 3.372 |
| October 15, 2026 | 3.366 |
| October 14, 2026 | 3.213 |
| October 13, 2026 | 3.266 |
| October 12, 2026 | 3.393 |
| October 09, 2026 | 3.321 |
| October 08, 2026 | 3.170 |
| October 07, 2026 | 3.215 |
| October 06, 2026 | 3.238 |
| October 05, 2026 | 3.238 |
| October 02, 2026 | 3.238 |
| October 01, 2026 | 3.264 |
| September 30, 2026 | 3.329 |
| September 29, 2026 | 3.310 |
| September 28, 2026 | 3.289 |
| September 25, 2026 | 3.191 |
| September 24, 2026 | 3.210 |
| September 23, 2026 | 3.441 |
| September 22, 2026 | 3.476 |
| September 21, 2026 | 2.743 |
| September 18, 2026 | 2.758 |
| September 17, 2026 | 2.871 |
| Date | Value |
|---|---|
| September 16, 2026 | 2.929 |
| September 15, 2026 | 2.968 |
| September 14, 2026 | 3.022 |
| September 11, 2026 | 3.013 |
| September 10, 2026 | 3.040 |
| September 09, 2026 | 3.011 |
| September 08, 2026 | 3.230 |
| September 04, 2026 | 3.210 |
| September 03, 2026 | 3.169 |
| September 02, 2026 | 3.273 |
| September 01, 2026 | 3.250 |
| August 31, 2026 | 3.255 |
| August 28, 2026 | 3.361 |
| August 27, 2026 | 3.503 |
| August 26, 2026 | 3.623 |
| August 25, 2026 | 3.726 |
| August 24, 2026 | 3.626 |
| August 21, 2026 | 3.605 |
| August 20, 2026 | 3.544 |
| August 19, 2026 | 3.644 |
| August 18, 2026 | 3.568 |
| August 17, 2026 | 3.424 |
| August 14, 2026 | 3.329 |
| August 13, 2026 | 3.389 |
| August 12, 2026 | 3.372 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.779 |
| Corcept Therapeutics, Inc. | 17.78 |
| Veru, Inc. | 1.382 |
| Johnson & Johnson | 7.611 |
| Eli Lilly & Co. | 35.31 |
Price to Book Value Related Metrics
| PS Ratio | 85.65 |
| PEG Ratio | -0.2548 |
| Price | 32.58 |
| Earnings Yield | -7.78% |
| Market Cap | 1.808B |
| PEGY Ratio | -0.2548 |